Market Closed -
Canadian Securities Exchange
15:57:07 2024-04-15 EDT
|
5-day change
|
1st Jan Change
|
0.045
CAD
|
-25.00%
|
|
-.--%
|
-30.77%
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
31.27
|
8.469
|
3.985
|
10.78
|
5.035
|
1.166
|
Enterprise Value (EV)
1 |
30.58
|
8.012
|
4.796
|
14.84
|
7.927
|
4.718
|
P/E ratio
|
-18.8
x
|
-3.15
x
|
-2.97
x
|
-1.16
x
|
-2.15
x
|
-0.43
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
3,272,358,964
x
|
138,020,294
x
|
-
|
-
|
-
|
EV / Revenue
|
-
|
3,095,862,828
x
|
166,073,140
x
|
-
|
-
|
-
|
EV / EBITDA
|
-25.2
x
|
-2.84
x
|
-7.33
x
|
-5.38
x
|
-8.87
x
|
-190
x
|
EV / FCF
|
-45.3
x
|
18.3
x
|
14.1
x
|
-26.6
x
|
-5.78
x
|
85
x
|
FCF Yield
|
-2.21%
|
5.46%
|
7.11%
|
-3.75%
|
-17.3%
|
1.18%
|
Price to Book
|
18.2
x
|
6.55
x
|
4.42
x
|
-7.92
x
|
-1.4
x
|
-0.2
x
|
Nbr of stocks (in thousands)
|
9,197
|
9,410
|
9,964
|
15,400
|
16,785
|
17,941
|
Reference price
2 |
3.400
|
0.9000
|
0.4000
|
0.7000
|
0.3000
|
0.0650
|
Announcement Date
|
1/28/19
|
1/28/20
|
1/28/21
|
2/7/22
|
2/6/23
|
5/16/24
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.002588
|
0.0289
|
-
|
-
|
-
|
EBITDA
1 |
-1.214
|
-2.826
|
-0.6543
|
-2.756
|
-0.8936
|
-0.0248
|
EBIT
1 |
-1.218
|
-2.835
|
-0.6763
|
-2.937
|
-1.553
|
-0.5517
|
Operating Margin
|
-
|
-109,532.88%
|
-2,342.01%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-1.586
|
-2.918
|
-1.378
|
-8.038
|
-2.166
|
-2.581
|
Net income
1 |
-1.569
|
-2.671
|
-1.27
|
-8.036
|
-2.166
|
-2.581
|
Net margin
|
-
|
-103,208.81%
|
-4,397.25%
|
-
|
-
|
-
|
EPS
2 |
-0.1812
|
-0.2859
|
-0.1345
|
-0.6049
|
-0.1395
|
-0.1500
|
Free Cash Flow
1 |
-0.6754
|
0.4375
|
0.341
|
-0.5569
|
-1.372
|
0.0555
|
FCF margin
|
-
|
16,906.45%
|
1,181.04%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/28/19
|
1/28/20
|
1/28/21
|
2/7/22
|
2/6/23
|
5/16/24
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
0.81
|
4.06
|
2.89
|
3.55
|
Net Cash position
1 |
0.69
|
0.46
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-1.238
x
|
-1.473
x
|
-3.236
x
|
-143.3
x
|
Free Cash Flow
1 |
-0.68
|
0.44
|
0.34
|
-0.56
|
-1.37
|
0.06
|
ROE (net income / shareholders' equity)
|
-285%
|
-176%
|
-121%
|
3,596%
|
87.6%
|
55.1%
|
ROA (Net income/ Total Assets)
|
-64.9%
|
-86.4%
|
-20%
|
-57.2%
|
-47.3%
|
-473%
|
Assets
1 |
2.416
|
3.092
|
6.359
|
14.06
|
4.577
|
0.5451
|
Book Value Per Share
2 |
0.1900
|
0.1400
|
0.0900
|
-0.0900
|
-0.2100
|
-0.3300
|
Cash Flow per Share
2 |
0.1000
|
0.0500
|
0
|
0.0100
|
0
|
0
|
Capex
1 |
0.38
|
0.02
|
-
|
0.74
|
-
|
-
|
Capex / Sales
|
-
|
718.93%
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/28/19
|
1/28/20
|
1/28/21
|
2/7/22
|
2/6/23
|
5/16/24
|
|
1st Jan change
|
Capi.
|
---|
| -30.77% | 803K | | -37.75% | 341M | | -.--% | 339M | | +52.26% | 299M | | +35.05% | 279M | | +57.56% | 206M | | +52.17% | 138M | | +167.98% | 137M | | -28.57% | 122M | | +34.62% | 118M |
Medical Farming
|